TP53 mutations in advanced colorectal cancer: The dark side of the moon

2014

Background: Evidence for TP53 mutations as biomarker in colorectal cancer (CRC) is conflicting. Methods:

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

20

References

6

Citations